Right to Contraception Act

Bill Number

S. 422

Origin Chamber

Senate

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-02-05: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Last Updated

2025-12-05T21:39:17Z

AI-Generated Summary

Purpose of the Legislation

The Right to Contraception Act (S. 422) aims to establish a clear statutory right for individuals to access and use contraceptives without interference, and for health care providers to offer related services and information. It seeks to protect personal decision-making about reproductive health, family planning, and bodily autonomy, enabling equal participation in economic and social life. The bill responds to historical and ongoing barriers to contraception, emphasizing its role in public health, equality, and human rights.

Key Provisions

• Definitions (Section 2):
• Contraception: Any action to prevent pregnancy, including drugs, devices, fertility-awareness methods, or sterilization.
• Contraceptive: FDA-approved or authorized drugs, devices, or biological products for preventing pregnancy (even if they serve other health purposes).
• Broad definitions of government (federal, state, local entities) and health care provider (licensed doctors, nurses, pharmacists, etc.), with state including territories, tribes, and localities.

• Findings (Section 3): Congress asserts the constitutional and human rights basis for contraception access, citing Supreme Court cases (e.g., Griswold v. Connecticut for married couples, Eisenstadt v. Baird for all individuals). It highlights benefits like preventing unintended pregnancies, improving health outcomes, reducing maternal/infant mortality, and addressing historical reproductive coercion (e.g., forced sterilizations). The section notes barriers for marginalized groups (e.g., people of color, LGBTQ+ individuals, low-income or rural residents) and invokes Congress's authority under the Commerce Clause and 14th Amendment.

• Permitted Services (Section 5):
• Individuals have a right to obtain and use contraceptives voluntarily, free from coercion.
• Health care providers have a right to supply contraceptives, services, information, and referrals.
• Prohibits any federal, state, or local laws, rules, or policies that single out or impede access to these rights, unless proven (by clear and convincing evidence) to significantly advance access without less restrictive options.
• Preserves FDA's authority to regulate and approve contraceptives.

• Applicability and Preemption (Section 6):
• Overrides conflicting federal and state laws (existing or future), including the Religious Freedom Restoration Act (RFRA).
• Bans enforcement of restrictions on selling, providing, using, or aiding access to contraceptives.
• Does not alter health insurance coverage requirements under laws like the Affordable Care Act or Medicaid.
• Takes effect immediately upon enactment; can be raised as a defense in legal actions.

• Rules of Construction (Section 7): Courts must interpret the Act broadly to achieve its goals. It prohibits government interference in provider services or patient access and requires voluntary, informed consent for sterilizations. Individuals enforcing violating policies are treated as government officials.

• Enforcement (Section 8):
• U.S. Attorney General can sue states or officials to invalidate violating policies.
• Private lawsuits allowed by affected individuals, providers (on behalf of themselves, staff, or patients), or entities, with courts able to issue injunctions (temporary or permanent) and award costs/attorney's fees to prevailing plaintiffs.
• Federal courts have jurisdiction; no exhaustion of other remedies required.
• Waives state immunity under the 10th and 11th Amendments for challenges.

• Severability (Section 9): If any part is ruled unconstitutional, the rest remains in effect.

Significant Changes to Existing Law

• Codifies contraception as a statutory right, building on but going beyond Supreme Court precedents by preempting state and federal restrictions that previously allowed refusals based on personal beliefs (e.g., in 12 states) or funding limits (e.g., in Arkansas, Mississippi).
• Overrides RFRA, preventing religious objections from blocking access, unlike some prior interpretations.
• Introduces strong enforcement tools, including private rights of action and abrogation of state sovereign immunity, which were not uniformly available before.
• Explicitly excludes abortion from its scope while protecting emergency contraception and preventing expansive state definitions that conflate the two.

Potential Impacts

• On Citizens: Enhances nationwide access to contraceptives, reducing barriers for underserved groups and potentially lowering unintended pregnancy rates, maternal health risks, and health disparities. It empowers personal choices but does not mandate insurance coverage changes.
• On Government Agencies: Empowers the Attorney General and HHS/FDA for enforcement and regulation; requires states to align policies, potentially increasing federal oversight of state health programs like Medicaid.
• On Health Care Providers: Shields providers from penalties for offering services, reducing refusals and enabling consistent care delivery, though it does not address provider conscience protections beyond preemption.
• On International Relations: Aligns U.S. policy with global standards (e.g., UN and WHO recognitions of contraception as a human right), potentially strengthening U.S. advocacy for reproductive health in foreign aid and diplomacy, without direct international mandates.

Main Stakeholders Affected

• Individuals: All people seeking contraception, especially marginalized communities (e.g., Black, Indigenous, low-income, rural, LGBTQ+, disabled, or immigrant populations) facing historical or current barriers.
• Health Care Providers: Doctors, nurses, pharmacists, and facilities providing reproductive services, who gain protections against restrictive laws.
• Governments: Federal agencies (e.g., DOJ for enforcement, FDA for approvals); states, localities, and tribes, which must comply or face lawsuits, potentially shifting policy from restriction to facilitation.
• Insurers and Programs: Entities under Medicaid or ACA, unaffected in coverage but indirectly impacted by ensured access to approved products.

Notable Legal, Constitutional, or Political Implications

• Legal: Creates robust remedies (e.g., injunctions, fee-shifting) to challenge restrictions swiftly in federal courts, lowering barriers to litigation and promoting uniform national standards. The "clear and convincing evidence" burden for exceptions sets a high bar against limits.
• Constitutional: Relies on Commerce Clause (interstate aspects of health care) and 14th Amendment (equal protection) authority; counters Dobbs v. Jackson Women's Health Organization (2022) concerns by statutorily safeguarding rights Justice Thomas suggested revisiting. Liberal construction rule favors broad protection.
• Political: Introduced by a bipartisan Congress but sponsored by Democratic senators; signals federal intervention in reproductive rights amid state-level variations post-Dobbs, potentially sparking debates on federalism, religious freedoms, and public health priorities. Severability ensures resilience against partial invalidation.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Markey, Edward J. [D-MA]

Cosponsors (41)

Sen. Duckworth, Tammy [D-IL], Sen. Hirono, Mazie K. [D-HI], Sen. Baldwin, Tammy [D-WI], Sen. Bennet, Michael F. [D-CO], Sen. Blumenthal, Richard [D-CT], Sen. Booker, Cory A. [D-NJ], Sen. Blunt Rochester, Lisa [D-DE], Sen. Cantwell, Maria [D-WA], Sen. Coons, Christopher A. [D-DE], Sen. Cortez Masto, Catherine [D-NV], Sen. Durbin, Richard J. [D-IL], Sen. Gallego, Ruben [D-AZ], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Heinrich, Martin [D-NM], Sen. Hickenlooper, John W. [D-CO], Sen. Kaine, Tim [D-VA], Sen. Kim, Andy [D-NJ], Sen. Klobuchar, Amy [D-MN], Sen. Merkley, Jeff [D-OR], Sen. Murphy, Christopher [D-CT], Sen. Murray, Patty [D-WA], Sen. Ossoff, Jon [D-GA], Sen. Padilla, Alex [D-CA], Sen. Peters, Gary C. [D-MI], Sen. Reed, Jack [D-RI], Sen. Rosen, Jacky [D-NV], Sen. Sanders, Bernard [I-VT], Sen. Schatz, Brian [D-HI], Sen. Shaheen, Jeanne [D-NH], Sen. Slotkin, Elissa [D-MI], Sen. Smith, Tina [D-MN], Sen. Van Hollen, Chris [D-MD], Sen. Warner, Mark R. [D-VA], Sen. Warnock, Raphael G. [D-GA], Sen. Warren, Elizabeth [D-MA], Sen. Welch, Peter [D-VT], Sen. Whitehouse, Sheldon [D-RI], Sen. Wyden, Ron [D-OR], Sen. Fetterman, John [D-PA], Sen. Lujan, Ben Ray [D-NM], Sen. Alsobrooks, Angela D. [D-MD]

Recent Actions

• 2025-02-05: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
• 2025-02-05: Introduced in Senate

Bill Versions

• Right to Contraception Act — issued 2025-02-05 — PDF (17 pages)

Related Bills

• H.R. 999 (119th Congress)